Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

The acute effects of allulose and fructose on postprandial carbohydrate metabolism

FY 2015-16

Summary
Functional food therapies for individuals with type 2 diabetes mellitus (T2DM) target the improvement of clinical endpoints (i.e. blood sugar), and can be easily incorporated into the diet. Allulose, a sugar that is structurally similar to fructose, has the potential to be a functional food ingredient for individuals with T2DM due to its ability to decrease caloric intake (0.2kcal/g) and reduce post-meal blood glucose spikes. However, there are few human trials investigating the effects of allulose on post-meal blood glucose responses and it is currently not approved for use in Canadian food products. Therefore, we propose 2 projects to investigate the effect of allulose on post-meal blood sugar control. The first project will consist of a short-term trial testing the equivalence of allulose and fructose at various intake levels on post-meal blood glucose and insulin responses in those with and without T2DM. My project will analyze the results from participants without T2DM. The second project will consist of a systematic review and meta-analysis on the short-term effects of allulose ingestion on post-meal blood glucose levels compared to other sugars. Together these two projects will demonstrate whether allulose is equivalent or not to fructose in terms of its ability to lower post-meal blood glucose and insulin responses. Furthermore, these studies and the emerging literature that will stem from it will contribute to the development of novel functional food therapies for those with T2DM and therefore the prevention and management of T2DM. Given that in Canada, 60% of the population is overweight or obese and 22% have diabetes, this project is necessary to find therapies that target weight loss and the treatment and management of T2DM.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
350128
Name
Braunstein Catherine R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The acute effects of allulose and fructose on postprandial carbohydrate metabolism
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Allulose; Catalytic Dose; Equivalence Trial; Fructose; Iauc Plasma Glucose; Iauc Plasma Insulin; Oral Glucose Tolerance Test; Otherwise Healthy; Randomized Crossover Trial; Type 2 Diabetes
Abstract
Functional food therapies for individuals with type 2 diabetes mellitus (T2DM) target the improvement of clinical endpoints (i.e. blood sugar), and can be easily incorporated into the diet. Allulose, a sugar that is structurally similar to fructose, has the potential to be a functional food ingredient for individuals with T2DM due to its ability to decrease caloric intake (0.2kcal/g) and reduce post-meal blood glucose spikes. However, there are few human trials investigating the effects of allulose on post-meal blood glucose responses and it is currently not approved for use in Canadian food products. Therefore, we propose 2 projects to investigate the effect of allulose on post-meal blood sugar control. The first project will consist of a short-term trial testing the equivalence of allulose and fructose at various intake levels on post-meal blood glucose and insulin responses in those with and without T2DM. My project will analyze the results from participants without T2DM. The second project will consist of a systematic review and meta-analysis on the short-term effects of allulose ingestion on post-meal blood glucose levels compared to other sugars. Together these two projects will demonstrate whether allulose is equivalent or not to fructose in terms of its ability to lower post-meal blood glucose and insulin responses. Furthermore, these studies and the emerging literature that will stem from it will contribute to the development of novel functional food therapies for those with T2DM and therefore the prevention and management of T2DM. Given that in Canada, 60% of the population is overweight or obese and 22% have diabetes, this project is necessary to find therapies that target weight loss and the treatment and management of T2DM.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Braunstein, Catherine R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~